Jehangir Clinical Development Centre Pvt. Ltd.   Report issue

For profit Phase 1 Phase 2 Phase 4
Founded: Pune India (2008)

Organization Overview

First Clinical Trial
2009
NCT00923702
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

Clinical Development Centre Pvt. Ltd. | Jehangir Clinical Development Centre | Jehangir Clinical development Centre Pvt Ltd

Active Ingredients

Drugs in Phase 4 Trials (1)

human papillomavirus quadrivalent (types 6, 11, 16 and 18) vaccine, recombinant (Gardasil) (1 trial)

Drugs in Phase 2 Trials (1)

grc 17356 (1 trial)

Drugs in Phase 1 Trials (1)

centhaquin (Lyfaquin) (1 trial)

Drugs in Other Trials (2)

clindamycin (cleocin) (1 trial)

tretinoin (Retin-A) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetic Neuropathies (Phase 2)

Pain (Phase 2)

Peripheral Nervous System Diseases (Phase 2)

Uterine Cervical Neoplasms (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 5